JP2007529539A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007529539A5 JP2007529539A5 JP2007504041A JP2007504041A JP2007529539A5 JP 2007529539 A5 JP2007529539 A5 JP 2007529539A5 JP 2007504041 A JP2007504041 A JP 2007504041A JP 2007504041 A JP2007504041 A JP 2007504041A JP 2007529539 A5 JP2007529539 A5 JP 2007529539A5
- Authority
- JP
- Japan
- Prior art keywords
- complex
- poly
- group
- hydrogel
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000017 hydrogel Substances 0.000 claims 13
- 239000003112 inhibitor Substances 0.000 claims 12
- 229920000642 polymer Polymers 0.000 claims 12
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 6
- -1 carboxylate esters Chemical group 0.000 claims 6
- 239000002131 composite material Substances 0.000 claims 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 5
- 229920003169 water-soluble polymer Polymers 0.000 claims 5
- 239000003153 chemical reaction reagent Substances 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 229920000233 poly(alkylene oxides) Polymers 0.000 claims 4
- 150000007970 thio esters Chemical group 0.000 claims 4
- 150000004657 carbamic acid derivatives Chemical group 0.000 claims 3
- 150000004649 carbonic acid derivatives Chemical group 0.000 claims 3
- 229920001184 polypeptide Polymers 0.000 claims 3
- 239000002243 precursor Substances 0.000 claims 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims 3
- 150000001241 acetals Chemical group 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 150000008064 anhydrides Chemical group 0.000 claims 2
- 125000004104 aryloxy group Chemical group 0.000 claims 2
- 229920001577 copolymer Polymers 0.000 claims 2
- 239000000499 gel Substances 0.000 claims 2
- 150000002466 imines Chemical group 0.000 claims 2
- 229940121292 leronlimab Drugs 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 150000002905 orthoesters Chemical group 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 150000003014 phosphoric acid esters Chemical group 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 125000006850 spacer group Chemical group 0.000 claims 2
- GXINKQQWHLIBJA-UCIBKFKQSA-N (z)-but-2-enedioic acid;(4,6-dimethylpyrimidin-5-yl)-[4-[(3s)-4-[(1r)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl]methanone Chemical compound OC(=O)\C=C/C(O)=O.N([C@@H](COC)C=1C=CC(=CC=1)C(F)(F)F)([C@H](C1)C)CCN1C(CC1)(C)CCN1C(=O)C1=C(C)N=CN=C1C GXINKQQWHLIBJA-UCIBKFKQSA-N 0.000 claims 1
- 108010036239 CD4-IgG(2) Proteins 0.000 claims 1
- WSNMPAVSZJSIMT-UHFFFAOYSA-N COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 Chemical compound COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 WSNMPAVSZJSIMT-UHFFFAOYSA-N 0.000 claims 1
- 208000031886 HIV Infections Diseases 0.000 claims 1
- 208000037357 HIV infectious disease Diseases 0.000 claims 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 239000003443 antiviral agent Substances 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 238000001879 gelation Methods 0.000 claims 1
- 229920001519 homopolymer Polymers 0.000 claims 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims 1
- 229920001477 hydrophilic polymer Polymers 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000035515 penetration Effects 0.000 claims 1
- 125000001997 phenyl group Chemical class [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 230000004962 physiological condition Effects 0.000 claims 1
- 229920000765 poly(2-oxazolines) Polymers 0.000 claims 1
- 229920001584 poly(acrylomorpholines) Polymers 0.000 claims 1
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 1
- 125000005415 substituted alkoxy group Chemical group 0.000 claims 1
- 150000003573 thiols Chemical class 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 0 CCC(C)(C)NC(O*(**)=C)=O Chemical compound CCC(C)(C)NC(O*(**)=C)=O 0.000 description 5
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55314604P | 2004-03-15 | 2004-03-15 | |
| US60/553,146 | 2004-03-15 | ||
| PCT/US2005/008632 WO2005089805A2 (en) | 2004-03-15 | 2005-03-15 | Polymer-based compositions and conjugates of hiv entry inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007529539A JP2007529539A (ja) | 2007-10-25 |
| JP2007529539A5 true JP2007529539A5 (enExample) | 2008-03-27 |
| JP4805911B2 JP4805911B2 (ja) | 2011-11-02 |
Family
ID=34994420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007504041A Expired - Fee Related JP4805911B2 (ja) | 2004-03-15 | 2005-03-15 | Ｈｉｖ侵入阻害剤のポリマー系組成物及び複合体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9446139B2 (enExample) |
| EP (1) | EP1725262B1 (enExample) |
| JP (1) | JP4805911B2 (enExample) |
| KR (1) | KR101276422B1 (enExample) |
| CN (1) | CN101132812A (enExample) |
| AU (1) | AU2005222641B2 (enExample) |
| CA (1) | CA2558583C (enExample) |
| MX (1) | MXPA06010505A (enExample) |
| WO (1) | WO2005089805A2 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE444984T1 (de) * | 2002-12-31 | 2009-10-15 | Nektar Therapeutics Al Corp | Hydrolysestabile maleimidendgruppen-enthaltende polymere |
| US7432331B2 (en) * | 2002-12-31 | 2008-10-07 | Nektar Therapeutics Al, Corporation | Hydrolytically stable maleimide-terminated polymers |
| EP1708734A4 (en) * | 2004-01-07 | 2009-06-17 | Trimeris Inc | PEPTIDES DERIVED FROM HIV GP41 HR2 AND THEIR USE IN THERAPY TO INHIBIT THE TRANSMISSION OF HUMAN IMMUNODICIENCY VIRUS |
| DE102004031258A1 (de) * | 2004-06-29 | 2006-02-09 | Jennissen, Herbert P., Prof. Dr. | Proteinhybride mit polyhydroxyaromatischen Aminosäure-Epitopen |
| EP1885403B1 (en) * | 2005-04-12 | 2013-05-08 | Nektar Therapeutics | Poly(ethyleneglycol) conjugates of Lysostaphin |
| PT1989220E (pt) * | 2006-02-02 | 2012-03-23 | Trimeris Inc | Péptidos inibidores de fusão de hiv com propriedades biológicas melhoradas |
| US7671067B2 (en) * | 2006-02-09 | 2010-03-02 | Enzon Pharmaceuticals, Inc. | Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamtothecin |
| US7462627B2 (en) * | 2006-02-09 | 2008-12-09 | Enzon Pharmaceuticals, Inc. | Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers |
| MX2008010841A (es) | 2006-02-21 | 2008-10-27 | Nektar Therapeutics Al Corp | Polimeros degradables segmentados y conjugados hechos de los mismos. |
| US20090285780A1 (en) * | 2006-05-24 | 2009-11-19 | Chyi Lee | Peg linker compounds and biologically active conjugates thereof |
| EP2054074B8 (en) | 2006-08-04 | 2014-11-12 | Prolong Pharmaceuticals, LLC | Modified erythropoietin |
| BRPI0807232A2 (pt) * | 2007-02-09 | 2014-04-29 | Enzon Pharmaceuticals Inc | Tratamento de cânceres resistentes ou refratários com conjugados poliméricos multi-braços de 7-etil-10-hidroxicamptotecina |
| EP2134181A4 (en) * | 2007-02-28 | 2011-09-28 | Serina Therapeutics Inc | ACTIVATED POLYOXAZOLINES AND COMPOSITION COMPRISING THE SAME |
| US20140011964A1 (en) | 2007-02-28 | 2014-01-09 | Serina Therapeutics, Inc. | Activated Polyoxazolines and Conjugates and Compositions Comprising the Same |
| CA2682848A1 (en) * | 2007-04-03 | 2008-10-16 | Trimeris, Inc. | Novel formulations for delivery of antiviral peptide therapeutics |
| BRPI0817697A2 (pt) * | 2007-09-25 | 2015-04-07 | Trimeris Inc | Método de síntese de um peptídeo, conjunto de fragmentos de peptídeo, e, peptídeo |
| TW201010732A (en) * | 2008-08-29 | 2010-03-16 | Enzon Pharmaceuticals Inc | Method of treating RAS associated cancer |
| CN102215688A (zh) * | 2008-10-21 | 2011-10-12 | 安龙制药公司 | 用7-乙基-10-羟基喜树碱的多臂聚合物对神经母细胞瘤的治疗 |
| HUE043689T2 (hu) * | 2009-11-18 | 2019-09-30 | Nektar Therapeutics | Polimer-gyógyszer savas sói |
| WO2011084458A2 (en) * | 2009-12-15 | 2011-07-14 | The Johns Hopkins University | Polymer-based compositions and methods for treatment of peritoneal disorders |
| US20110295365A1 (en) * | 2010-05-28 | 2011-12-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Anti-viral compositions and methods for administration |
| WO2013158454A2 (en) * | 2012-04-18 | 2013-10-24 | Siemens Healthcare Diagnostics Inc. | Compounds and methods for preparation of conjugate reagents |
| CN104109240A (zh) * | 2014-07-13 | 2014-10-22 | 成都市绿科华通科技有限公司 | 一种可作为药物载体的多孔聚乙二醇的制备方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992013947A1 (en) | 1991-02-08 | 1992-08-20 | Progenics Pharmaceuticals, Inc. | CD4-GAMMA2 AND CD4-IgG2 CHIMERAS |
| US5446090A (en) * | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
| US5932462A (en) * | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| US5792462A (en) * | 1995-05-23 | 1998-08-11 | University Of North Carolina At Chapel Hill | Alphavirus RNA replicon systems |
| EP1411075B1 (en) * | 1998-03-12 | 2008-07-02 | Nektar Therapeutics Al, Corporation | Method for preparing polymer conjugates |
| US6656906B1 (en) * | 1998-05-20 | 2003-12-02 | Trimeris, Inc. | Hybrid polypeptides with enhanced pharmacokinetic properties |
| US20040228869A1 (en) | 1998-12-16 | 2004-11-18 | Progenics Pharmaceuticals, Inc. | Synergistic inhibition of HIV-1 fusion and attachment, compositions and antibodies thereto |
| US6469136B1 (en) | 1999-07-07 | 2002-10-22 | Trimeris, Inc. | Methods and composition for peptide synthesis |
| US6541020B1 (en) | 1999-07-09 | 2003-04-01 | Trimeris, Inc. | Methods and compositions for administration of therapeutic reagents |
| US6413507B1 (en) * | 1999-12-23 | 2002-07-02 | Shearwater Corporation | Hydrolytically degradable carbamate derivatives of poly (ethylene glycol) |
| AU2001238595A1 (en) | 2000-02-22 | 2001-09-03 | Shearwater Corporation | N-maleimidyl polymer derivatives |
| WO2001064710A2 (en) | 2000-02-29 | 2001-09-07 | Progenics Pharmaceuticals, Inc. | Sulfated ccr5 peptides for hiv-1 infection |
| CN100352837C (zh) * | 2002-07-24 | 2007-12-05 | 弗·哈夫曼-拉罗切有限公司 | 聚乙二醇化的t1249多肽 |
| DE60335111D1 (de) * | 2002-07-24 | 2011-01-05 | Hoffmann La Roche | Pegyliertes t20-polypeptid |
| AU2003258518B2 (en) | 2002-07-24 | 2007-01-18 | F. Hoffmann-La Roche Ag | Polyalkylene glycol acid additives |
| EP1546235B1 (en) * | 2002-09-09 | 2021-10-20 | Nektar Therapeutics | Water-soluble polymer alkanals |
| US7556813B2 (en) | 2002-09-27 | 2009-07-07 | Trimeris, Inc. | Antiviral peptide-polymer conjugate comprising a polymer covalently attached to two or more synthetic HIV gp41 HR1 and/or HR2 peptides |
| CA2508015C (en) | 2002-12-30 | 2012-04-03 | Nektar Therapeutics Al, Corporation | Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles |
| AU2003300140A1 (en) * | 2002-12-31 | 2004-07-29 | Nektar Therapeutics Al, Corporation | Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof |
| AU2003300139B2 (en) * | 2002-12-31 | 2008-08-28 | Nektar Therapeutics | Maleamic acid polymer derivatives and their bioconjugates |
| DE602004029646D1 (en) * | 2003-01-06 | 2010-12-02 | Nektar Therapeutics San Carlos | Thiolselektive wasserlösliche polymerderivate |
| SI1596887T1 (sl) * | 2003-02-26 | 2022-05-31 | Nektar Therapeutics | Konjugati polimer-del faktorja VIII |
| KR101128320B1 (ko) | 2003-05-23 | 2012-04-12 | 넥타르 테라퓨틱스 | 아미도카르보네이트 연결기를 갖는 ｐｅｇ 유도체 |
| EP1734994A1 (en) | 2004-03-15 | 2006-12-27 | Trimeris, Inc. | Site-specific chemical modification of hiv gp41-derived peptides |
-
2005
- 2005-03-15 JP JP2007504041A patent/JP4805911B2/ja not_active Expired - Fee Related
- 2005-03-15 US US11/082,229 patent/US9446139B2/en not_active Expired - Fee Related
- 2005-03-15 AU AU2005222641A patent/AU2005222641B2/en not_active Ceased
- 2005-03-15 KR KR1020067019107A patent/KR101276422B1/ko not_active Expired - Fee Related
- 2005-03-15 EP EP05725666.1A patent/EP1725262B1/en not_active Expired - Lifetime
- 2005-03-15 CA CA2558583A patent/CA2558583C/en not_active Expired - Lifetime
- 2005-03-15 MX MXPA06010505A patent/MXPA06010505A/es active IP Right Grant
- 2005-03-15 CN CNA2005800082104A patent/CN101132812A/zh active Pending
- 2005-03-15 WO PCT/US2005/008632 patent/WO2005089805A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007529539A5 (enExample) | ||
| USRE46234E1 (en) | Tissue adhesive and sealant comprising polyglycerol aldehyde | |
| US8951989B2 (en) | Hydrogel tissue adhesive having reduced degradation time | |
| JP5123939B2 (ja) | 弾性が改良された組織接着剤 | |
| JP2009519961A5 (enExample) | ||
| US8680200B2 (en) | Polyglycerol aldehydes | |
| JP2013500726A5 (enExample) | ||
| JP2017511322A5 (enExample) | ||
| WO2010005740A3 (en) | Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles | |
| JP2005520006A5 (enExample) | ||
| JP2012526548A5 (enExample) | ||
| CN102181060A (zh) | 聚乙烯醇-聚肽-聚乙二醇接枝共聚物及其制备方法 | |
| JP2005538224A (ja) | 水溶性ポリマーアルカナール | |
| JP2011080089A5 (enExample) | ||
| WO2011112482A3 (en) | Polymeric drug delivery conjugates and methods of making and using thereof | |
| EP1974726A3 (en) | Matrix compositions for controlled delivery of drug substances | |
| Li et al. | Synthesis of linear polyether polyol derivatives as new materials for bioconjugation | |
| EP2448604A2 (en) | Hydrogel tissue adhesive for medical use | |
| KR20190142569A (ko) | 폴리락틱산 강인화제용 조성물, 이를 통해 제조된 강인화성 폴리락틱산 공중합체 및 이의 제조방법 | |
| CN1613890A (zh) | 一种生物可降解性聚酯接枝聚磷腈共聚物及其制备方法 | |
| CN114269812A (zh) | 基于可交联亲水聚合物的医用组合物 | |
| CN113813440B (zh) | 一种生物粘附性可调的水凝胶材料及其制备方法和应用 | |
| CN1291759C (zh) | 聚n－乙烯基吡咯烷酮与聚乙烯醇共混压敏胶及其应用 | |
| JP4341312B2 (ja) | ポリエチレングリコール含有共重合体 | |
| CN119613981B (zh) | 一种高粘高弹改性沥青及沥青组合物 |